Misuse preventative, controlled release formulation

Details for Australian Patent Application No. 2009327312 (hide)

Owner LABOPHARM EUROPE LIMITED LABOPHARM INC. Labopharm (Barbados) Limited

Inventors Rahmouni, Miloud; Gervais, Sonia; Sant, Vinayak; Smith, Damon; Duffayet, Frederic; Rustom, Shams; El-Jammal, Ali; Ndong, Jean-Michel; Boursiquot, Bobby-Ernst; Bichara, Ali

Agent Griffith Hack

Pub. Number AU-A-2009327312

PCT Pub. Number WO2010/069050

Priority 61/138,092 16.12.08 US

Filing date 16 December 2009

Wipo publication date 24 June 2010

International Classifications

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 9/24 (2006.01) Medicinal preparations characterised by special physical form - Layered or laminated unitary dosage forms

A61K 9/30 (2006.01) Medicinal preparations characterised by special physical form - Organic coatings

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

Event Publications

4 August 2011 PCT application entered the National Phase

  PCT publication WO2010/069050 Priority application(s): WO2010/069050

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009327316-[2.2.2] bicyclic derivatives and methods of use

2009327308-A method to control the dispersibility and barrier properties of dried nanocrystalline cellulose in solutions of different pH and ionic strength